Maxiflo Rotacaps

✅ Efficient respiratory relief
✅ Convenient rotacap format
✅ Targeted medication delivery
✅ Improved COPD management

contains Fluticasone propionate and Formoterol Fumarate

Product Overview

Maxiflo Rotacaps is a combination respiratory medication containing Fluticasone propionate and Formoterol Fumarate. This dual-action formulation effectively addresses respiratory conditions while enhancing lung function.

Therapeutic Applications

This medication is specifically indicated for:

  • Prevention and management of asthma symptoms
  • Treatment of chronic obstructive pulmonary disease (COPD)
  • Management of chronic bronchitis and emphysema

It effectively alleviates breathing difficulties and respiratory distress.

Mechanism of Action

The combined action of both active ingredients provides comprehensive respiratory relief:

  • Fluticasone propionate: A potent corticosteroid that reduces airway inflammation and swelling
  • Formoterol Fumarate: A long-acting beta-agonist that relaxes bronchial muscles

This synergistic effect facilitates easier breathing and improved airflow.

Recommended Usage

For optimal results:

  • Administer via Rotahaler inhalation device only
  • Follow prescribed dosage regimen strictly
  • Never ingest capsules orally
  • Maintain regular medical supervision

Key Advantages

  • Dual therapeutic action targeting both inflammation and bronchoconstriction
  • Sustained relief from respiratory symptoms
  • Enhanced pulmonary performance
  • Effective for long-term management of chronic respiratory conditions

Potential Adverse Effects

Some patients may experience:

  • Oropharyngeal irritation
  • Dysphonia (voice changes)
  • Cephalalgia (headaches)
  • Increased susceptibility to respiratory infections
  • Cardiovascular effects (palpitations)

Consult your physician if symptoms persist or worsen.

Important Precautions

  • Not indicated for acute bronchospasm relief
  • Requires medical consultation for pregnant/lactating women
  • Potential drug interactions – disclose all concurrent medications
  • Contraindicated in pediatric patients under 4 years

Storage Guidelines

  • Store at controlled room temperature (15-30°C)
  • Protect from moisture and light
  • Keep securely closed in original packaging
  • Dispose of expired medication properly
Strength

100mcg + 6mcg, 250mcg + 6mcg, 500mcg + 12mcg

Quantity

30 Rotacap/s, 60 Rotacap/s, 90 Rotacap/s

Pharma Form

Rotacaps

Manufacturer

Cipla Inc

Treatment

Asthma

Reviews

There are no reviews yet

Add a review
Maxiflo Rotacaps Maxiflo Rotacaps
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
* Please confirm that you are not a robot